ABCA9

gene
On this page

Also known as EST640918

Summary

ABCA9 (ATP binding cassette subfamily A member 9, HGNC:39) is a protein-coding gene on chromosome 17q24.2, encoding ATP-binding cassette sub-family A member 9 (Q8IUA7). Transporter that may play a role in monocyte differentiation and lipid transport and homeostasis.

This gene is a member of the superfamily of ATP-binding cassette (ABC) transporters and the encoded protein contains two transmembrane domains and two nucleotide binding folds. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, and White). This gene is a member of the ABC1 subfamily and is clustered with four other ABC1 family members on chromosome 17q24. Transcriptional expression of this gene is induced during monocyte differentiation into macrophages and is suppressed by cholesterol import.

Source: NCBI Gene 10350 — RefSeq curated summary.

At a glance

  • GWAS associations: 4
  • Clinical variants (ClinVar): 243 total
  • MANE Select transcript: NM_080283

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:39
Approved symbolABCA9
NameATP binding cassette subfamily A member 9
Location17q24.2
Locus typegene with protein product
StatusApproved
AliasesEST640918
Ensembl geneENSG00000154258
Ensembl biotypeprotein_coding
OMIM612507
Entrez10350

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 4 protein_coding, 3 retained_intron, 1 protein_coding_CDS_not_defined

ENST00000340001, ENST00000453985, ENST00000460872, ENST00000461623, ENST00000482072, ENST00000492580, ENST00000495634, ENST00000585714

RefSeq mRNA: 1 — MANE Select: NM_080283 NM_080283

CCDS: CCDS11681

Canonical transcript exons

ENST00000340001 — 39 exons

ExonStartEnd
ENSE000010148846902038869020586
ENSE000010148886898616468986324
ENSE000010148896901841369018579
ENSE000010148926901765669017789
ENSE000010148956901197669012083
ENSE000010148986900806269008235
ENSE000010148996902764069027815
ENSE000010149016903210869032276
ENSE000010149066903372669033873
ENSE000011048676899589568996014
ENSE000011048786902916969029227
ENSE000011049076898902768989118
ENSE000011049106899301668993084
ENSE000011049216900775969007872
ENSE000011049266902853569028645
ENSE000017008406897448868976013
ENSE000024438076902637769026467
ENSE000024484576902733069027449
ENSE000024547106898488568984979
ENSE000024569416902174269021861
ENSE000024869346902421469024353
ENSE000025078986898981368989930
ENSE000025107816902697669027114
ENSE000025115726899217568992266
ENSE000025333786898505368985128
ENSE000029011426904928369049490
ENSE000029036756905103169051139
ENSE000029616876906086669060927
ENSE000034624056899083768990957
ENSE000034992366904517269045336
ENSE000035206506904348969043715
ENSE000035534766898370968983849
ENSE000035898116898405668984175
ENSE000035930936903524669035431
ENSE000036442236903566069035801
ENSE000036732376904449769044600
ENSE000036831596897613568976190
ENSE000036840796901625369016390
ENSE000036875096898256268982641

Expression profiles

Bgee: expression breadth ubiquitous, 229 present calls, max score 98.21.

FANTOM5 (CAGE): breadth broad, TPM avg 2.3254 / max 113.6806, expressed in 463 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
1677701.8953438
1677710.3992174
1677720.02436
1677690.00644

Top tissues by expression

253 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
mucosa of stomachUBERON:000119998.21gold quality
tibial nerveUBERON:000132397.50gold quality
sural nerveUBERON:001548896.41gold quality
left ovaryUBERON:000211995.28gold quality
left ventricle myocardiumUBERON:000656695.27gold quality
omental fat padUBERON:001041495.20gold quality
peritoneumUBERON:000235895.14gold quality
subcutaneous adipose tissueUBERON:000219094.46gold quality
right ovaryUBERON:000211894.15gold quality
cardiac muscle of right atriumUBERON:000337994.07gold quality
adipose tissue of abdominal regionUBERON:000780894.06gold quality
pericardiumUBERON:000240793.57gold quality
apex of heartUBERON:000209892.19gold quality
right atrium auricular regionUBERON:000663192.18gold quality
cardiac atriumUBERON:000208192.15gold quality
lower esophagus muscularis layerUBERON:003583392.02gold quality
lower esophagusUBERON:001347391.94gold quality
esophagogastric junction muscularis propriaUBERON:003584191.91gold quality
right lungUBERON:000216791.10gold quality
left uterine tubeUBERON:000130391.08gold quality
right coronary arteryUBERON:000162591.08gold quality
adipose tissueUBERON:000101391.04gold quality
ovaryUBERON:000099290.25gold quality
endocervixUBERON:000045889.39gold quality
gastrocnemiusUBERON:000138889.35gold quality
calcaneal tendonUBERON:000370189.30gold quality
heartUBERON:000094889.11gold quality
heart left ventricleUBERON:000208488.95gold quality
left coronary arteryUBERON:000162688.69gold quality
coronary arteryUBERON:000162188.63gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-GEOD-180759yes1652.15
E-ANND-3yes40.50
E-HCAD-35yes6.65
E-MTAB-7606no5.55

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 2)

  • Novel key genes in triple-negative breast cancer identified by weighted gene co-expression network analysis. (PMID:31081967)
  • ABCA9, an ER cholesterol transporter, inhibits breast cancer cell proliferation via SREBP-2 signaling. (PMID:36576228)

Cross-species orthologs

16 orthologs

OrganismSymbolGene ID
danio_rerioabca5ENSDARG00000074041
mus_musculusAbca9ENSMUSG00000041797
rattus_norvegicusAbca9ENSRNOG00000059326
drosophila_melanogasterEatoFBGN0028539
drosophila_melanogasterCG1494FBGN0031169
drosophila_melanogasterAbca3FBGN0031170
drosophila_melanogasterCG1801FBGN0031171
drosophila_melanogasterCG8908FBGN0034493
drosophila_melanogasterCG6052FBGN0036747
drosophila_melanogasterCG31213FBGN0051213
drosophila_melanogasterlddFBGN0083956
drosophila_melanogasterCG43672FBGN0263747
caenorhabditis_elegansWBGENE00000019
caenorhabditis_elegansabt-2WBGENE00000020
caenorhabditis_elegansWBGENE00000022
caenorhabditis_elegansabt-5WBGENE00000023

Paralogs (11): ABCA7 (ENSG00000064687), ABCA2 (ENSG00000107331), ABCA8 (ENSG00000141338), ABCA12 (ENSG00000144452), ABCA6 (ENSG00000154262), ABCA10 (ENSG00000154263), ABCA5 (ENSG00000154265), ABCA1 (ENSG00000165029), ABCA3 (ENSG00000167972), ABCA13 (ENSG00000179869), ABCA4 (ENSG00000198691)

Protein

Protein identifiers

ATP-binding cassette sub-family A member 9Q8IUA7 (reviewed: Q8IUA7)

All UniProt accessions (3): Q8IUA7, H0Y4U7, K7EJJ0

UniProt curated annotations — full annotation on UniProt →

Function. Transporter that may play a role in monocyte differentiation and lipid transport and homeostasis.

Subcellular location. Membrane.

Tissue specificity. Widely expressed with higher expression in heart.

Induction. Up-regulated during monocyte differentiation into macrophages. Down-regulated by cholesterol loading of macrophages.

Similarity. Belongs to the ABC transporter superfamily. ABCA family.

Isoforms (5)

UniProt IDNamesCanonical?
Q8IUA7-11yes
Q8IUA7-22, ABCA9delta+55
Q8IUA7-33, ABCA9delta+73
Q8IUA7-44, ABCA9delta-95
Q8IUA7-55

RefSeq proteins (1): NP_525022* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR003439ABC_transporter-like_ATP-bdDomain
IPR003593AAA+_ATPaseDomain
IPR013525ABC2_TMDomain
IPR026082ABCAFamily
IPR027417P-loop_NTPaseHomologous_superfamily

Pfam: PF00005, PF12698

UniProt features (32 total): transmembrane region 14, splice variant 5, sequence variant 4, glycosylation site 3, domain 2, binding site 2, chain 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8IUA7-F177.220.14

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (2): 517–524; 1326–1333

Glycosylation sites (3): 120, 195, 949

Function

Pathways and Gene Ontology

Reactome pathways

3 pathways

IDPathway
R-HSA-1369062ABC transporters in lipid homeostasis
R-HSA-382551Transport of small molecules
R-HSA-382556ABC-family protein mediated transport

MSigDB gene sets: 91 (showing top): IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR, KEGG_ABC_TRANSPORTERS, TGTGTGA_MIR377, COATES_MACROPHAGE_M1_VS_M2_UP, GOBP_LIPID_LOCALIZATION, NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON, CAGCCTC_MIR4855P, GOBP_TRANSMEMBRANE_TRANSPORT, GOMF_LIPID_TRANSPORTER_ACTIVITY, GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ACID_ANHYDRIDES, GOMF_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_ATP_HYDROLYSIS_ACTIVITY, GOMF_ADENYL_NUCLEOTIDE_BINDING, GOMF_TRANSPORTER_ACTIVITY, CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP

GO Biological Process (2): lipid transport (GO:0006869), transmembrane transport (GO:0055085)

GO Molecular Function (6): lipid carrier activity (GO:0005319), ATP binding (GO:0005524), ATP hydrolysis activity (GO:0016887), ATPase-coupled transmembrane transporter activity (GO:0042626), ABC-type transporter activity (GO:0140359), nucleotide binding (GO:0000166)

GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-2 pathways:

CategoryPathways
ABC-family protein mediated transport1
Transport of small molecules1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
transport2
ATP-dependent activity2
lipid localization1
cellular process1
molecular carrier activity1
adenyl ribonucleotide binding1
purine ribonucleoside triphosphate binding1
ribonucleoside triphosphate phosphatase activity1
primary active transmembrane transporter activity1
ATP hydrolysis activity1
ATPase-coupled transmembrane transporter activity1
nucleoside phosphate binding1
heterocyclic compound binding1
membrane1
cell periphery1
cellular anatomical structure1

Protein interactions and networks

STRING

872 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ABCA9ABCC3O15438459
ABCA9ABCC9O60706457
ABCA9ABCD4O14678443
ABCA9ABCF3Q9NUQ8389
ABCA9ABCF1Q8NE71362
ABCA9OR56B4Q8NH76348
ABCA9ZFAND4Q86XD8311
ABCA9LYPD2Q6UXB3300
ABCA9ABCA13Q86UQ4284
ABCA9PCOLCE2Q9UKZ9282
ABCA9ABCC8Q09428281
ABCA9SLC37A3Q8NCC5279
ABCA9ABCA12Q86UK0278
ABCA9ABCB8Q9NUT2277
ABCA9SLC16A14Q7RTX9274

IntAct

7 interactions, top by confidence:

ABTypeScore
Mpsi-mi:“MI:0914”(association)0.350
MYCpsi-mi:“MI:0914”(association)0.350
ABCA10POTEFpsi-mi:“MI:0914”(association)0.350
ABCA9SERPINB8psi-mi:“MI:0914”(association)0.350
ABCA9PMM2psi-mi:“MI:0914”(association)0.350
ABCA9DEDDpsi-mi:“MI:0915”(physical association)0.000

BioGRID (9): ABCA9 (Two-hybrid), ABCA9 (Affinity Capture-MS), SERPINB8 (Affinity Capture-MS), BLK (Affinity Capture-MS), GET4 (Affinity Capture-MS), PMM1 (Affinity Capture-MS), PMM2 (Affinity Capture-MS), ABCA9 (Cross-Linking-MS (XL-MS)), EEA1 (Cross-Linking-MS (XL-MS))

ESM2 similar proteins: A0A0G2K1Q8, B2RX12, E9PU17, E9PX95, F1MWM0, O00329, O15438, O35600, O75899, O88563, O88871, O94911, O95477, P41233, P55205, P58428, P78363, Q09427, Q09428, Q09429, Q2NKY8, Q5BJS0, Q5R607, Q5ZI74, Q6TL19, Q7L2E3, Q7TNJ2, Q80T41, Q84M24, Q8CF82, Q8IUA7, Q8K440, Q8K441, Q8K442, Q8K448, Q8K449, Q8LPK0, Q8N139, Q8NCL4, Q8R420

Diamond homologs: A0A059J0G5, A0A0G2K1Q8, A0A1L9WQK0, A0A1U8QKX8, A0A1U8QT10, A0A1V0QSE4, A0A1V1GB10, A0A1Y0BRF0, A0A2H1A768, A0A2U8U2K9, A0A481WQK1, A0A4P8GG95, A0A8K1AW53, A1C8C8, A1CFM0, A9YWR6, B6HV31, B6RAL1, B8NDS8, B9G5Y5, D3GE74, D4AYW0, D4GSY7, E9PU17, E9PX95, E9RBG1, F2PLH2, F2RSQ6, F2SG60, F2SHL1, G3JF11, I1RL06, J9VME1, J9VPA2, M2UCE5, O42690, O65934, O74208, O74676, P10090

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

243 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance203
Likely benign20
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

5607 predictions. Top by Δscore:

VariantEffectΔscore
17:68975925:T:Adonor_gain1.0000
17:68976011:AACC:Aacceptor_loss1.0000
17:68976013:CCTAA:Cacceptor_loss1.0000
17:68976014:CTAA:Cacceptor_loss1.0000
17:68976191:C:CCacceptor_gain1.0000
17:68983705:CTA:Cdonor_loss1.0000
17:68983706:TACCT:Tdonor_loss1.0000
17:68983707:ACC:Adonor_loss1.0000
17:68983708:CCT:Cdonor_loss1.0000
17:68983712:T:Adonor_gain1.0000
17:68983845:TACAT:Tacceptor_gain1.0000
17:68983847:CAT:Cacceptor_gain1.0000
17:68983849:TCT:Tacceptor_loss1.0000
17:68983850:C:CCacceptor_gain1.0000
17:68983850:CTGA:Cacceptor_loss1.0000
17:68984049:CACT:Cdonor_loss1.0000
17:68984050:ACTC:Adonor_loss1.0000
17:68984051:CTCA:Cdonor_loss1.0000
17:68984052:TCAC:Tdonor_loss1.0000
17:68984053:CACCT:Cdonor_loss1.0000
17:68984055:C:CGdonor_loss1.0000
17:68984174:GC:Gacceptor_gain1.0000
17:68984175:CC:Cacceptor_gain1.0000
17:68985047:CCGTA:Cdonor_loss1.0000
17:68985048:CGTAC:Cdonor_loss1.0000
17:68985049:GTACC:Gdonor_loss1.0000
17:68985050:TA:Tdonor_loss1.0000
17:68985051:ACC:Adonor_loss1.0000
17:68985052:C:Adonor_loss1.0000
17:68985124:CTAAC:Cacceptor_gain1.0000

AlphaMissense

10699 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:69016319:G:CS991R0.992
17:69016319:G:TS991R0.992
17:69016321:T:GS991R0.992
17:69027010:G:CS672R0.991
17:69027010:G:TS672R0.991
17:69027012:T:GS672R0.991
17:69035276:G:CS366R0.990
17:69035276:G:TS366R0.990
17:69035278:T:GS366R0.990
17:68989079:T:AK1332I0.988
17:69028609:G:TA514D0.987
17:69044511:C:GA187P0.987
17:69017682:C:GA959P0.986
17:69026410:A:GL703P0.986
17:69028582:T:AK523I0.986
17:69044536:A:CF178L0.985
17:69044536:A:TF178L0.985
17:69044538:A:GF178L0.985
17:69026406:C:AK704N0.984
17:69026406:C:GK704N0.984
17:69027364:A:GL626P0.982
17:69024243:A:GL751S0.981
17:69027692:A:GL580P0.981
17:68989075:A:CS1333R0.979
17:68989075:A:TS1333R0.979
17:68989077:T:GS1333R0.979
17:69016346:G:CC982W0.978
17:69044548:C:AW174C0.977
17:69044548:C:GW174C0.977
17:69045221:A:CF140L0.977

dbSNP variants (sampled 300 via entrez): RS1000031406 (17:69043311 A>G), RS1000036002 (17:69004262 G>A,T), RS1000056733 (17:69050390 A>G), RS1000121805 (17:69062869 T>C), RS1000174919 (17:69013845 T>G), RS1000220360 (17:68978781 A>G), RS1000223047 (17:68991898 A>G), RS1000240268 (17:69015649 G>C), RS1000311054 (17:69074356 C>T), RS1000321574 (17:69028880 G>A,C), RS1000344004 (17:69073969 T>A), RS1000469189 (17:68993186 C>G), RS1000485118 (17:68990478 C>G,T), RS1000527925 (17:69008648 G>C), RS1000529384 (17:69008349 C>A,T)

Disease associations

OMIM: gene MIM:612507 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

4 associations (top):

StudyTraitp-value
GCST008176_4Gestational age at birth (child effect)5.000000e-06
GCST009533_5Circulating leptin levels x sex interaction in high cardiovascular risk9.000000e-06
GCST012310_10Schizophrenia x sex interaction3.000000e-06
GCST012311_26Schizophrenia x sex interaction5.000000e-06

EFO canonical traits (3, from GWAS)

EFO IDTrait name
EFO:0005112gestational age
EFO:0005000leptin measurement
EFO:0008343sex interaction measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: transporter — ABCA subfamily

CTD chemical–gene interactions

17 total (human), top 17 by PubMed support.

ChemicalActions (top 5)PubMed papers
Nickeldecreases expression2
bisphenol Aincreases methylation1
lead acetatedecreases expression1
mono-(2-ethylhexyl)phthalatedecreases expression1
manganese chlorideincreases expression1
CGP 52608affects binding, increases reaction1
abrineincreases expression1
incobotulinumtoxinAincreases expression1
Docetaxeldecreases response to substance, increases expression1
Arsenic Trioxideincreases expression1
Acetaminophendecreases expression1
Benzo(a)pyreneaffects methylation1
Cadmiumdecreases expression1
Doxorubicindecreases expression1
Manganeseincreases expression1
Tobacco Smoke Pollutiondecreases expression1
Okadaic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.